NCT06834074
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06834074 |
| Title | Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC (NVL-655-EAP) |
| Acronym | NVL-655-EAP |
| Recruitment | Available |
| Gender | both |
| Phase | Expanded access |
| Variant Requirements | Yes |
| Sponsors | Nuvalent Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | NLD | GBR | FRA | CHE | CAN | AUS |
CKB BOOST